Riverside, CA, United States of America

Fidel Melgar

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Kap Medical, Inc.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fidel Melgar. Retrieved from https://idiyas.com/inventor/fidel-melgar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Inventive Journey of Fidel Melgar

Introduction: Fidel Melgar, a talented inventor based in Riverside, CA, has made significant contributions to the field of technology through his innovative creations and patents.

Latest Patents: Fidel Melgar holds several patents in the areas of renewable energy technologies, smart home devices, and medical innovations, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Fidel Melgar has successfully brought several groundbreaking inventions to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Fidel Melgar has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, demonstrating his commitment to innovation and progress.

Conclusion: Fidel Melgar's dedication to innovation and his remarkable ability to turn ideas into reality make him a standout figure in the world of inventors, with a promising future ahead in shaping the technological landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…